Cite
Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension.
MLA
Ferdinand, Keith C., et al. “Efficacy and Safety of Aliskiren-Based Dual and Triple Combination Therapies in US Minority Patients with Stage 2 Hypertension.” Journal of the American Society of Hypertension, vol. 5, no. 2, Mar. 2011, pp. 102–13. EBSCOhost, https://doi.org/10.1016/j.jash.2011.01.006.
APA
Ferdinand, K. C., Weitzman, R., Israel, M., Lee, J., Purkayastha, D., & Jaimes, E. A. (2011). Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension. Journal of the American Society of Hypertension, 5(2), 102–113. https://doi.org/10.1016/j.jash.2011.01.006
Chicago
Ferdinand, Keith C., Richard Weitzman, Marc Israel, Joleen Lee, Das Purkayastha, and Edgar A. Jaimes. 2011. “Efficacy and Safety of Aliskiren-Based Dual and Triple Combination Therapies in US Minority Patients with Stage 2 Hypertension.” Journal of the American Society of Hypertension 5 (2): 102–13. doi:10.1016/j.jash.2011.01.006.